Beam Therapeutics Inc. (BEAM) Net margin 2019–2025
Beam Therapeutics Inc. (BEAM) net profit margin by fiscal year — reported net income divided by reported revenue.
-57.2%FY2025 · since FY2019: -435144.4% → -57.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -57.2% | +535.9 pp |
| FY2024 | -593.1% | -558.0 pp |
| FY2023 | -35.1% | +439.5 pp |
| FY2022 | -474.5% | +240.4 pp |
| FY2021 | -714.9% | +810085.1 pp |
| FY2020 | -810800.0% | -375655.6 pp |
| FY2019 | -435144.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net incomeBEAM Gross profitBEAM Gross marginBEAM Operating incomeBEAM Operating marginBEAM Operating cash flowBEAM Free cash flowBEAM Capital expendituresBEAM Return on equityBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Total liabilitiesBEAM Shareholders’ equityBEAM overview →